An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector

Oncolytic (replication-competent) adenoviruses as anticancer agents provide new, promising tools to fight cancer. In support of a Phase I clinical trial, here we report safety data with INGN 007 (VRX-007), an oncolytic adenovirus with increased anti-tumor efficacy due to overexpression of the adenov...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lichtenstein, DL, Spencer, JF, Doronin, K, Patra, D, Meyer, JM, Shashkova, EV, Kuppuswamy, M, Dhar, D, Thomas, MA, Tollefson, AE, Zumstein, LA, Wold, WSM, Toth, K
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433943/
https://ncbi.nlm.nih.gov/pubmed/19197324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2009.5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados